Skanska has finalized a contract with Seagen to construct a 25,000 square meter biomanufacturing facility for the global biotechnology company. The facility will include manufacturing, storage, shipping, office, and café space in Everett, Washington, USA. The contract is worth USD 215 M, about SEK 2.25 billion, which will be included in the U.S. order bookings for the third quarter, 2023.
Seagen announced their plans to build the project in April 2022. Construction is underway and completion is anticipated for Q4, 2024.
For further information please contact:
Daniela Arellano, Communications Director, Skanska USA, tel +1 213 317 4977
Olof Rundgren, Media Relations Manager, Skanska AB, tel +46 (0)10 448 67 94
Direct line for media, tel +46 (0)10 448 88 99
